Overview

Doxorubicin is an anthracycline antibiotic with potent antitumor activity. It acts by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals that damage cancer cell membranes and DNA. It is one of the most active single agents in veterinary oncology, particularly against lymphoma, and forms the “H” in the CHOP lymphoma protocol used in dogs, cats, and ferrets.

Doxorubicin is a hazardous cytotoxic drug with a narrow safety margin. It must be administered only by a veterinary oncology team experienced in chemotherapy handling, extravasation management, and anthracycline-specific toxicity monitoring. All handlers — clinic staff and owners — must follow strict chemotherapy safety protocols.

Uses

  • Lymphoma — central component of CHOP and multi-agent lymphoma protocols in ferrets, dogs, and cats
  • Osteosarcoma in dogs (adjuvant post-amputation)
  • Hemangiosarcoma in dogs
  • Various carcinomas and sarcomas as part of combination protocols

In ferrets, doxorubicin is used in modified CHOP protocols for lymphoma, with dose and scheduling adapted to the small body size and species-specific sensitivities.

Dosage

Only oncology-experienced clinicians should prescribe and administer doxorubicin. Ferret dosing is commonly extrapolated from feline oncology:

  • Typical ferret dose: approximately 1 mg/kg IV slowly over 20-30 minutes (published ferret doses vary)
  • Given as part of a multi-agent rotation (example: day 1 of week 5 and week 11 in a modified CHOP cycle)
  • Administered only through a clean, patent IV catheter placed specifically for the infusion
  • Maximum cumulative lifetime dose is limited by cardiotoxicity (in cats roughly 180 mg/m²; ferret thresholds not well defined)

Dose volumes in a 1 kg ferret are extremely small, emphasizing the need for meticulous preparation and dedicated oncology compounding.

Side Effects

Doxorubicin has several distinctive toxicities:

  • Myelosuppression — nadir at 7-10 days post-dose; neutropenia can be severe
  • GI toxicity — nausea, vomiting, anorexia, diarrhea, colitis
  • Cardiotoxicity — cumulative, dose-dependent dilated cardiomyopathy; particularly important in dogs, less well characterized in ferrets
  • Extravasation injury — severe tissue necrosis and sloughing if drug leaks outside the vein; a surgical emergency
  • Hypersensitivity reactions — facial swelling, urticaria, rarely anaphylaxis during infusion
  • Red-orange urine for 24-48 hours (normal, not hematuria)
  • Alopecia — variable across species
  • Renal toxicity in cats — less common in ferrets but monitored

Handling and Safety Warnings

  • Cytotoxic hazard to humans. Doxorubicin is classified as a hazardous drug; it is vesicant, mutagenic, and possibly carcinogenic.
  • Chemotherapy PPE required. Double nitrile gloves, gown, mask, and eye protection during preparation and administration.
  • Prepare in a biological safety cabinet with closed-system transfer devices.
  • Extravasation protocol must be ready before administration — dexrazoxane is the antidote for doxorubicin extravasation and should be on hand.
  • Post-treatment waste handling: wear gloves when handling urine, feces, vomit, litter, and bedding for at least 48-72 hours. Double-bag waste.
  • Pregnant women, women or partners trying to conceive, nursing mothers, children, and immunocompromised individuals must not handle the drug or the treated patient’s waste.

Drug Interactions

  • Other cardiotoxic drugs — avoid concurrent use
  • Phenobarbital, phenytoin — may reduce doxorubicin levels
  • Verapamil, cyclosporine — may increase doxorubicin toxicity
  • Live vaccines — avoid during and shortly after chemotherapy
  • Other myelosuppressive agents — additive toxicity

Contraindications

  • Pre-existing cardiac disease (use cautiously or avoid)
  • Significant hepatic dysfunction (drug is hepatically metabolized)
  • Active infection with neutropenia
  • Known hypersensitivity to anthracyclines
  • Pregnant handlers should never prepare or administer the drug

FAQs

Is doxorubicin safe in ferrets? It can be used with acceptable tolerability in oncology practice, but it is not a drug to be used outside a specialty setting. Cardiac and bone marrow monitoring are essential.

Why is my ferret’s urine orange after a dose? Doxorubicin is naturally red-orange and colors urine for 24-48 hours. This is normal and expected — it is not blood.

What happens if the drug leaks during infusion? Extravasation of doxorubicin causes severe tissue necrosis. Treatment is an emergency involving dexrazoxane, cold compresses, and possibly surgical debridement. This is why only trained oncology staff should place the IV and administer the infusion.

How is cardiotoxicity monitored? Echocardiography is used in dogs; ferret monitoring is typically by clinical examination and cumulative dose tracking.

Can I take my ferret home right after treatment? Usually yes, once the infusion is complete and the patient is stable. Follow all home waste-handling precautions for 48-72 hours.